Replies to post #34671 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

If you are talking about the phase I/II part/phase 2, I think/infer it is already ongoing.

Regarding the first of the independent phase 2 treatment indications and parameters, I assume at any time. Phase I dosing is complete in the current trial. We have capital resources. There should be enough data from the recent CI trials to place the final touches on any adjuvant arms (if there are any adjuvant arms), and it was supposed to be announced last fall. Now that the patient investor fund is established, I guess I see little holding us back.